CT
REGN icon

Columbia Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Columbia Trust’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$1.11M Buy
1,265
+142
+13% +$117K 0.5% 62
2023
Q3 		$924K Buy
1,123
+9
+0.8% +$7.07K 0.54% 60
2023
Q2 		$800K Buy
1,114
+7
+0.6% +$5.4K 0.45% 64
2023
Q1 		$910K Sell
1,107
-38
-3% -$28.7K 0.53% 56
2022
Q4 		$826K Buy
1,145
+33
+3% +$24.3K 0.46% 65
2022
Q3 		$766K Buy
1,112
+140
+14% +$88.1K 0.43% 67
2022
Q2 		$575K Buy
972
+505
+108% +$328K 0.31% 80
2022
Q1 		$342K Buy
+467
New +$295K 0.16% 119

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Columbia Trust's REGN Position: Q4 2023 in Review

Columbia Trust increased its Regeneron Pharmaceuticals (REGN) stake by 13% in Q4 2023, buying an estimated $117K and bringing the position to 1,265 shares worth $1.11M. The position accounts for 0.5% of the portfolio, ranked #62.

Columbia Trust first reported a position in REGN in Q1 2022 and has held it in 8 quarters since. 1,272 funds tracked by Wall St. Rank hold REGN as of Q4 2023.

  • Columbia Trust held 1,265 shares of Regeneron Pharmaceuticals worth $1.11M as of Q4 2023.
  • Columbia Trust bought 142 Regeneron Pharmaceuticals shares in Q4 2023, an estimated $117K.
  • Regeneron Pharmaceuticals made up 0.5% of Columbia Trust's portfolio in Q4 2023, its #62 holding.
  • Columbia Trust first reported a position in Regeneron Pharmaceuticals in Q1 2022 and has held it in 8 quarters since.
  • 1,272 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2023.

Based on Columbia Trust's 13F filing for Q4 2023, filed 17 Jan 2024.